Cipla Signals Deal Appetite, Readies New Growth Avenues In Mental Health, Obesity
Promoter Family Member Resigns
Cipla, which has a healthy cash position, outlines areas of deal interest in India and the US, where sterile injectable sites could be on its radar. The company is also set to tap new frontiers of growth, including in areas such as mental health and obesity.
